Literature DB >> 19454458

Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

S Cascinu1, S Jelic.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19454458     DOI： 10.1093/annonc/mdp123

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  10 in total

1.  Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portosplenomesenteric venous invasion.

Authors:  Takehiro Okabayashi; Yasuo Shima; Jun Iwata; Sojiro Morita; Tatsuaki Sumiyoshi; Akihito Kozuki; Yuichi Saisaka; Teppei Tokumaru; Tatsuo Iiyama; Yoshihiro Noda; Yasuhiro Hata; Manabu Matsumoto
Journal:  Langenbecks Arch Surg       Date:  2015-05-06       Impact factor: 3.445

Review 2.  Investigation and management of pancreatic tumours.

Authors:  Lyn A Smith; Nigel B Jamieson; Colin J McKay
Journal:  Frontline Gastroenterol       Date:  2013-10-11

3.  Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies.

Authors:  Natalia Khalaf; Chen Yuan; Tsuyoshi Hamada; Yin Cao; Ana Babic; Vicente Morales-Oyarvide; Peter Kraft; Kimmie Ng; Edward Giovannucci; Shuji Ogino; Meir Stampfer; Barbara B Cochrane; JoAnn E Manson; Clary B Clish; Andrew T Chan; Charles S Fuchs; Brian M Wolpin
Journal:  Gastroenterology       Date:  2017-12-08       Impact factor: 22.682

Review 4.  Targeted therapies for hepatocellular carcinoma.

Authors:  Augusto Villanueva; Josep M Llovet
Journal:  Gastroenterology       Date:  2011-03-13       Impact factor: 22.682

Review 5.  Splenectomy for non-haematological metastatic malignant disease.

Authors:  Piers A C Gatenby; Satvinder S Mudan; Andrew C Wotherspoon
Journal:  Langenbecks Arch Surg       Date:  2011-02-17       Impact factor: 3.445

6.  S-1 vs. gemcitabine as an adjuvant therapy after surgical resection for ductal adenocarcinoma of the pancreas.

Authors:  Takehiro Okabayashi; Yasuo Shima; Jun Iwata; Sojiro Morita; Tatsuaki Sumiyoshi; Akihito Kozuki; Teppei Tokumaru; Tatsuo Iiyama; Takuhiro Kosaki; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

7.  Pancreatic Squamous Cell Carcinoma: A Population-Based Study of Epidemiology, Clinicopathologic Characteristics and Outcomes.

Authors:  Oxana V Makarova-Rusher; Susanna Ulahannan; Tim F Greten; Austin Duffy
Journal:  Pancreas       Date:  2016-11       Impact factor: 3.327

8.  Quality appraisal of clinical practice guidelines on pancreatic cancer: a PRISMA-compliant article.

Authors:  Zhiyun He; Hongliang Tian; Ailin Song; Lan Jin; Xiaona Zhou; Xiaoye Liu; Wei Guo; Zhongtao Zhang
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

9.  Epidemiology, Treatment, and Outcome of Pancreatic Squamous Cell Carcinoma and Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis Based on SEER-Database.

Authors:  Yuqing Wang; Yuwen Zhou; Yueyun Chen; Ruolan Xia; Jiyan Liu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 10.  Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer.

Authors:  William Berry; Joanne Lundy; Daniel Croagh; Brendan J Jenkins
Journal:  Cancers (Basel)       Date:  2018-01-27       Impact factor: 6.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.